Chenji Wang

28PUBLICATIONS
45CO-AUTHORS
Cancer cell biologyMolecular targetsNeonatologySystem and network securityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 17, 2026
Correction: mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells.

|Jun 05, 2026
TSC22D4 drives clear cell renal cell carcinoma progression and therapy resistance by stabilizing NRF2 through KEAP1 disruption.

|Mar 14, 2026
DPP9 inhibition boosts antitumor immunity by disrupting BRISC-mediated PD-L1 expression in clear cell renal cell carcinoma.

Wei Zhang, Yue Wang, Tao Feng

|Mar 06, 2026
The TBCK-PPP1R21-FERRY3/C12orf4 complex: a RAB5-GAP brake essential for endo-lysosomal homeostasis.

Yingji Chen, Xiayun Xu, Yi Zheng

|Jul 23, 2025
Targeting the WSB2-NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors.

Dongyue Jiao, Kun Chang, Jiamin Jin

|Mar 27, 2025
SIRT7 regulates T-cell antitumor immunity through modulation BCAA and fatty acid metabolism.

Zuojian Hu, Yingji Chen, Jielin Lei

Pageof 5

Frequent Collaborators

8 joint publications

Shimin Zhao

8 joint publications

Kun Gao

6 joint publications

Yao Li

4 joint publications

Pingzhao Zhang